| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/05/2008 | US20080134355 Plants Having Improved Growth Characteristics And Method For Making The Same |
| 06/05/2008 | US20080134353 Using microspore and/or pollen mitotic induction discharge as tool in generating haploid plant cells |
| 06/05/2008 | US20080134351 Using vector transformation to generate recombinant plants which express preferential exogenous gene sequences |
| 06/05/2008 | US20080132686 Monoclonal antibody which binds insulin-like growth factor receptor (IGF-IR ) for use in diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents |
| 06/05/2008 | US20080132584 nanoscale dimensions enabling the non-destructive penetration of lipid membranes; functionalized to perform a bio-chemical process using bio-compatible, porous coating in which enzymes are structurally constrained |
| 06/05/2008 | US20080132484 Screening for a modulator of Polio Like Kinase, designing and identifying small molecule inhibitors using a homology model for PLK |
| 06/05/2008 | US20080132462 Administering an agent which inhibits the expression or activity of p46 Shc and/or p52 Shc; determining whether an agent inhibits the phosphorylation of p46 Shc or p52 Shc |
| 06/05/2008 | US20080132461 Introducing RNA which targets the mRNA of the gene for degradation into the cell or organism; maintaining the cell or organism, maintaining the cell or organism under conditions under which degradation of the mRNA occurs |
| 06/05/2008 | US20080132460 Screening for a compound which inhibits p62/ubiquitin binding; detecting the formation of inclusion bodies in neurodegenerative diseases; screening for therapeutic agents that disperse the inclusions |
| 06/05/2008 | US20080132450 Pharmaceutical composition for suppression of apoptosis and method for delivering the same |
| 06/05/2008 | US20080132445 increasing milk production; inhibiting tumors; administering Galanin with prolactin; transgenic mammal |
| 06/05/2008 | US20080132443 inhibiting smooth muscle cell proliferation and/or migration; smooth muscle relaxation; increasing the contractile rate in heart muscle; promoting wound healing; reducing scar formation; disrupting focal adhesions; regulating actin polymerization; host cell; biomedical device |
| 06/05/2008 | US20080132427 Comprising vertebrate cell having both luciferase and heterologous proliferation factor receptor encoding nucleic acids |
| 06/05/2008 | US20080132423 Isolated cell lines for screening drug candidates and identifying novel expressed genes and druggable targets |
| 06/05/2008 | US20080132422 Based on substrate integrated multifunctional microelectrode arrays implementing stem cell technology; normal and pathogenic characteristics |
| 06/05/2008 | US20080131976 Novel G protein coupled receptor protein, DNA its ligand |
| 06/05/2008 | US20080131969 Expression vector comprising nucleotide sequences coding neomycin phosphotransferase gene sequences for use as selectable marker in genetic engineering |
| 06/05/2008 | US20080131968 Using infared radiation to depolarize mitochondrial membrane in order to enhance efficacy of antifungal, microbiocidal and antitumor agents |
| 06/05/2008 | US20080131967 Using cultured keratin synthesizing cells as therapeutic tools in treatment of chronic injury; regenerative medicine; tissue engineering |
| 06/05/2008 | US20080131966 Preparing solid support comprised of human placental stem cells for use in tissue regeneration and wound healing |
| 06/05/2008 | US20080131965 Preparing matrix comprising human or animal tissues for use in forming heart valve |
| 06/05/2008 | US20080131964 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 06/05/2008 | US20080131963 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
| 06/05/2008 | US20080131962 Engineered cleavage half-domains |
| 06/05/2008 | US20080131951 Lipolytic Enzyme Variants |
| 06/05/2008 | US20080131946 Expression vector comprising nucleotide sequences coding lyase for use in transformation and expression in escherichia; producing scent compounds in micoorganism for use in cosmetics and food products |
| 06/05/2008 | US20080131940 Using expression vector comprising polymerase specific promoter to target and destroy cancer cells; antitumor agents; gene therapy |
| 06/05/2008 | US20080131934 Process For Cell Culturing By Continuous Perfusion And Alternating Tangential Flow |
| 06/05/2008 | US20080131932 Expression in filamentous fungi of protease inhibitors and variants thereof |
| 06/05/2008 | US20080131931 Expression vector comprising nucleotide sequences coding protein which binds interleukin-10 related t cell-derived inducible factor (IL-TIF); for use in targeting cell for surgical removal |
| 06/05/2008 | US20080131930 Means and methods for regulating gene expression |
| 06/05/2008 | US20080131929 Propagating chinese hamster ovary tissue in nutrient broth which lacks insulin |
| 06/05/2008 | US20080131920 Ion flux in biological processes, and methods related thereto |
| 06/05/2008 | US20080131913 Canine 5-Hydroxytryptamine 2A and 2B Receptor Materials and Their Use |
| 06/05/2008 | US20080131912 Recombinant antibodies against hepatitis C virus and methods of obtaining and using same |
| 06/05/2008 | US20080131900 Variants of alpha-fetoprotein coding and expression sequences |
| 06/05/2008 | US20080131881 Using monospecific immunoglobulins as diagnostic/prognostic tool in detecting nervous system disorders |
| 06/05/2008 | US20080131871 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators |
| 06/05/2008 | US20080131866 Tissue Preservation Media |
| 06/05/2008 | US20080131520 Silk fibroin from domesticated silkworm; sustained release; waste treatment |
| 06/05/2008 | US20080131480 New polyarylates for drug delivery and tissue engineering |
| 06/05/2008 | US20080131477 Device and method for tissue engineering |
| 06/05/2008 | US20080131476 Adherence, flexibility; suppressing air, blood and/or bodily fluid leakage from organ surface; culturing on support coated with temperature responsive polymer for easy detachment |
| 06/05/2008 | US20080131473 Cell-Independent Fabrication of Tissue Equivalents |
| 06/05/2008 | US20080131459 Vaccines, diagnostic agents; expression vectors for heterologous genes; deletion mutants, pseudorevertants, transfectants |
| 06/05/2008 | US20080131445 Cd127 expression inversely correlates with foxp3 and suppressive function of cd4+ tregs |
| 06/05/2008 | US20080131437 Using allelic variation in cell adhesion molecule (CD164) as tool in treatment and prevntion of skin, arthritic and gastrointestinal disorders |
| 06/05/2008 | US20080131436 Polypeptide Compounds for Inhibiting Angiogenesis and Tumor Growth |
| 06/05/2008 | US20080131435 Recombinant immunoglobulins to mediate cytotoxicity and treat cell proliferative disorders; immunotherapy |
| 06/05/2008 | US20080131433 Fc Receptor Homolog Antibodies And Uses Thereof |
| 06/05/2008 | US20080131431 CD47 related compositions and methods for treating immunological diseases and disorders |
| 06/05/2008 | US20080131428 Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| 06/05/2008 | US20080131427 Using mismatch repair inhibition as tool in directed polypeptide evolution |
| 06/05/2008 | US20080131423 Triggering receptors expressed on myeloid cells (TREMs) specific immunoglobulin for use in prevention and treatment of blood coagulation disorders |
| 06/05/2008 | US20080131422 Brain protein specific immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease |
| 06/05/2008 | US20080131415 Using cytotoxic t-lymphocytes as tumor targeting tools in treatment of cell proliferative disorders; immunotherapy |
| 06/05/2008 | US20080131411 Using vector transformation comprising wildtype fkhsf gene as therapeutic in prevention and treatment of skin and kidney disorders |
| 06/05/2008 | US20080131410 Placental stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
| 06/05/2008 | US20080131409 Methods and compositions for the treatment of medical disorders |
| 06/05/2008 | US20080131408 Hematopoietic stem cell culture for use in treatment and prevention of nervous system disorders; regenerative medicine; tissue engineering |
| 06/05/2008 | US20080131407 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 06/05/2008 | US20080131404 Hepatocytes |
| 06/05/2008 | US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases |
| 06/05/2008 | US20080131396 Using cytokine mixture as localizing tool in tissue target therapy of cell proliferative masses |
| 06/05/2008 | US20080131373 Fab proteins; anticancer agents; immunoglobulins; gene expression inhibition; kits |
| 06/05/2008 | US20080131366 Administering folate receptor alpha inducer comprising steroid receptor agent optionally with one or more histone deacetylase inhibitors to treat or diagnose a patient having a solid tumor; increases levels of receptors on cancer cell plasma membranes and in serum, ascites and cerebrospinal fluid |
| 06/05/2008 | US20080131365 Cancerous disease modifying antibodies |
| 06/05/2008 | DE10107186B4 Neue Form des PHGPx-Proteins als diagnostischer Marker bei männlicher Infertilität A new form of PHGPx protein as a diagnostic marker for male infertility |
| 06/05/2008 | CA2670949A1 Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same |
| 06/05/2008 | CA2670514A1 Optimized host cells for protein production |
| 06/05/2008 | CA2670433A1 Adoptive transfer of cd8+ t cell clones derived from central memory cells |
| 06/05/2008 | CA2669304A1 Use of a composition contaning human umbilical cord blood-derived mesenchymal stem cell for inducing differentiation and proliferation of neural precursor cells or neural stem cells to neural cells |
| 06/05/2008 | CA2668800A1 Tes7 and antibodies that bind thereto |
| 06/04/2008 | EP1927660A2 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions |
| 06/04/2008 | EP1927657A2 Compositions and methods for producing antigen-presenting cells |
| 06/04/2008 | EP1927656A1 Skin model |
| 06/04/2008 | EP1927600A1 Homogeneous preparations of IL-28 and IL-29 |
| 06/04/2008 | EP1927598A1 Vaccine |
| 06/04/2008 | EP1927368A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 06/04/2008 | EP1926813A2 Cell populations having immunoregulatory activity, method for isolation and uses |
| 06/04/2008 | EP1926812A2 Methods for rapidly and accurately locating avian egg blastoderms |
| 06/04/2008 | EP1926753A2 Hybrid enzymes consisting of an endo-amylase first amino acid sequence and a carbohydrate-binding module as second amino acid sequence |
| 06/04/2008 | EP1926750A2 Biological materials and uses thereof |
| 06/04/2008 | EP1926557A1 Kit for preparing a composition comprising fat cells |
| 06/04/2008 | EP1926459A2 Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof |
| 06/04/2008 | EP1926366A1 Plant extract and use thereof as a cryoprotective agent |
| 06/04/2008 | EP1463754B1 Cystine-knot fold protein |
| 06/04/2008 | EP1456357B1 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 06/04/2008 | EP1151304B9 METHOD OF IDENTIFYING N-TERMINAL proBNP |
| 06/04/2008 | EP1005534B1 Method for increasing the efficiency of recombinant aav production |
| 06/04/2008 | EP0946199B1 TGF beta 1-RESPONSIVE CELLS FROM BONE MARROW |
| 06/04/2008 | EP0920505B1 Mammalian cell surface antigens; related reagents |
| 06/04/2008 | EP0672143B1 Lymphotoxin-beta, lymphotoxin-beta complexes, pharmaceutical preparations and therapeutic uses thereof |
| 06/04/2008 | CN101194020A Process for production of L-amino acid |
| 06/04/2008 | CN101194015A Polypeptides having glucoamylase activity and polynucleotides encoding same |
| 06/04/2008 | CN101194012A Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines |
| 06/04/2008 | CN101193915A Monoclonal antibodies and methods for their use in the detection of cervical disease |
| 06/04/2008 | CN101193655A Vaccine against pandemic strains of influenza viruses |
| 06/04/2008 | CN101191131A Triticum timopheevi high molecular weight glutelin Gy7* gene and application thereof |
| 06/04/2008 | CN101191124A Separation method for Leydig cell and use thereof |